A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Inhibition of Osteoclastogenesis by LY90009 through Notch Signaling Modulation in Osteolytic Disease Models

499 views

DOI:

10.3791/69178

October 7th, 2025

In This Article

Summary

Here, we present a protocol to evaluate the inhibitory effects of the γ-secretase inhibitor LY900009 on RANKL-induced osteoclastogenesis in bone marrow-derived macrophages. The protocol includes cytotoxicity assessment, functional assays, molecular analyses, and in vivo validation in a murine osteolytic model, with applications in the therapeutic development of osteolytic diseases.

Abstract

Dysregulated osteoclast activity profoundly contributes to the progression of osteolytic disease, yet the extent of therapeutic intervention modalities is constrained by adverse effects. This study investigated LY900009, a γ-secretase inhibitor, and its capacity to suppress RANKL-induced osteoclastogenesis through modulation of Notch signaling. Using bone marrow-derived macrophages, we performed comprehensive in vitro evaluations of cytotoxicity, differentiation, and functional assays. Gene and protein expression analyses using qPCR and western blotting were used to elucidate the underlying molecular mechanisms. The in vivo efficacy was corroborated using a murine lipopolysaccharide-induced bone resorption model. LY900009 inhibited RANKL-induced osteoclast formation and resorptive function in a dose-dependent manner without cytotoxicity at therapeutic concentrations. This treatment significantly reduced the number of TRAP-positive osteoclasts, impaired actin belt formation, and suppressed bone matrix degradation. The expression of osteoclast markers, including NFATc1, c-Fos, cathepsin K, and TRAP, was markedly downregulated. Mechanistically, LY900009 disrupted Notch signaling and the downstream MAPK/Akt pathways. In vivo administration substantially reduced LPS-induced bone destruction, improving bone parameters and reducing osteoclast presence. These findings demonstrate that LY900009 effectively inhibits osteoclastogenesis and bone resorption by modulating the Notch/MAPK/Akt signaling axis, making it a promising therapeutic candidate for osteolytic disorders.

Introduction

Bone homeostasis constitutes an exquisitely orchestrated physiological paradigm in vertebrates, harmonized by the delicate equilibrium between osteoblast-mediated bone formation and osteoclast-driven bone resorption1. This intricate balance maintains skeletal integrity, biomechanical resilience, and metabolic fidelity throughout one's lifespan, dynamically responding to mechanical demands, endocrine perturbations, and pathological challenges2. The bone remodeling cycle involves sequential phases of activation, resorption, transition, formation, and termination, each governed by intricate molecular cascades that ensur....

Access restricted. Please log in or start a trial to view this content.

Protocol

All animal procedures were conducted in accordance with institutional guidelines and were approved by the Animal Care and Use Committee of the Central Hospital affiliated with Shandong First Medical University (approval number IACUC-2024-015). The study adhered to established ethical principles for animal research and ARRIVE guidelines, including animal housing in standard cages (5 mice/cage, 12-h light/dark cycle, ad libitum food/water) and randomization to groups

1. Bone marrow-derived macrophage isolation and culture

  1. Euthanize 5-week-old male C57BL/6 mice (n=5 per isolation) by placing them in a CO

Access restricted. Please log in or start a trial to view this content.

Results

The successful implementation of this protocol revealed that LY900009 exerted potent inhibitory effects on osteoclast formation and function through multiple interconnected mechanisms. Initial cytotoxicity assessment in bone marrow-derived macrophages demonstrated time-dependent increases in toxicity, with calculated IC50 values of 4.44 µM, 3.66 µM, and 2.93 µM at 24 h, 48 h, and 96 h, respectively (Figure 1A,B). Importantly, these cytotoxic concentrations were su.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The present investigation provides compelling evidence that LY900009 represents a promising therapeutic agent for osteolytic diseases through its potent and selective inhibition of osteoclastogenesis, consistent with the growing interest in γ-secretase inhibitors for bone-related disorders14,20,21. The findings demonstrate that this γ-secretase inhibitor effectively suppresses RANKL-induced osteoclast formation and bon.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no competing financial interests or conflicts of interest. No author has any financial relationship with the commercial entities mentioned in this work. All authors have completed the ICMJE disclosure forms.

Acknowledgements

The authors would like to thank the staff of the Central Hospital Affiliated to Shandong First Medical University and Feicheng People's Hospital for their technical support and assistance during the course of this study. We also appreciate the contributions of our laboratory colleagues for their valuable discussions and assistance with animal experiments.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
24-well cell culture platesCorning3524Immunofluorescence microscopy
6-well cell culture platesCorning3516Cell culture and western blot
70% EthanolSigma-AldrichE7023Sterilization and disinfection
75% EthanolSigma-AldrichE7148RNA washing buffer
96-well cell culture platesCorning3596Cell culture and assays
Aluminum filter (0.5 mm)BrukerN/AMicro-CT scanning filter
Anti-CD11b-FITC antibodyBioLegend101206Flow cytometry - macrophage marker
Anti-cleaved Notch1 antibody (rabbit monoclonal)Cell Signaling Technology4147SWestern blot - Notch signaling
Anti-F4/80-PE antibodyBioLegend123108Flow cytometry - macrophage marker
Anti-fade mounting mediumVector LaboratoriesH-1000Fluorescence microscopy mounting
Anti-Hes1 antibody (rabbit monoclonal)Cell Signaling Technology11988SWestern blot - Notch downstream target
Anti-NFATc1 antibody (mouse monoclonal)Santa Cruz Biotechnologysc-7294Western blot - osteoclast master regulator
Anti-phospho-Akt (Ser473) antibodyCell Signaling Technology4060SWestern blot - PI3K/Akt signaling
Anti-phospho-ERK1/2 (Thr202/Tyr204) antibodyCell Signaling Technology4370SWestern blot - MAPK signaling
Anti-phospho-NF-κB p65 (Ser536) antibodyCell Signaling Technology3033SWestern blot - NF-κB signaling
Anti-phospho-p38 MAPK (Thr180/Tyr182) antibodyCell Signaling Technology4511SWestern blot - p38 MAPK signaling
Anti-β-actin antibody (mouse monoclonal)Cell Signaling Technology4970SWestern blot loading control
Automated imaging readerMolecular DevicesImageXpress MicroResorption pit quantification
BCA Protein Assay KitPierce/Thermo Fisher23225Protein concentration determination
Bleach (10% sodium hypochlorite)Sigma-Aldrich425044Cell removal from resorption plates
BSA (Bovine Serum Albumin)Sigma-AldrichA7906Blocking buffer for immunofluorescence
C57BL/6 mice (male, 5-8 weeks old)Charles River Laboratories27In vitro BMM isolation and in vivo studies
Calcium oxalate test reagentSigma-AldrichC0350Decalcification completion testing
CCK-8 reagent (Cell Counting Kit-8)Dojindo Molecular TechnologiesCK04Cell viability assessment
Cell strainer (70 μm)BD Falcon352350Bone marrow cell filtration
Centrifuge (refrigerated)Eppendorf5424RCell and sample preparation
ChloroformSigma-AldrichC2432RNA extraction phase separation
CO2 chamberEuthanex CorpEX-075Animal euthanasia
CTAn softwareBrukerVersion 1.20Micro-CT image analysis
DAPI (4',6-diamidino-2-phenylindole)Sigma-AldrichD9542Nuclear counterstaining
Dimethylformamide (DMF)Sigma-AldrichD4551TRAP staining solvent
DMSO (Dimethyl sulfoxide)Sigma-AldrichD2650Vehicle control preparation
ECL Western Blotting SubstratePierce/Thermo Fisher32106Protein detection in western blot
EDTA (10%, pH 7.4)Sigma-AldrichE6758Decalcification solution
Eosin YSigma-AldrichE4009H&E histological staining
Fast Red Violet LB saltSigma-AldrichF3381TRAP staining chromogen
Fetal Bovine Serum (FBS)Gibco/Thermo Fisher16140-071Cell culture supplement
Flow cytometerBD BiosciencesFACSCaliburBMM characterization
Fluorescence microscopeOlympusIX73Immunofluorescence imaging
G*Power softwareHeinrich Heine UniversityVersion 3.1Statistical power analysis
Glass coverslips (22 × 22 mm)Fisher Scientific12-541-BImmunofluorescence microscopy
GraphPad PrismGraphPad SoftwareVersion 9.0IC50 calculation and graphing
HematoxylinSigma-AldrichH3136H&E histological staining
HemocytometerHausser Scientific3200Cell counting
High-Capacity cDNA Reverse Transcription KitApplied Biosystems4368814cDNA synthesis from RNA
HRP-conjugated anti-mouse IgGCell Signaling Technology7076SWestern blot secondary antibody
HRP-conjugated anti-rabbit IgGCell Signaling Technology7074SWestern blot secondary antibody
Hydroxyapatite-coated 96-well platesCorning BioCoat354651Bone resorption functional assay
ImageJNIHVersion 1.53eImage analysis and quantification
Incubator (CO2)Thermo Fisher51033058Cell culture maintenance
Infrared imaging systemBio-RadChemiDoc MPWestern blot detection
Inverted microscopeOlympusCKX41Cell culture monitoring, TRAP counting
IsopropanolSigma-AldrichI9516RNA precipitation
LPS (Lipopolysaccharide from E. coli)Sigma-AldrichL4391In vivo inflammatory bone resorption
LY900009 (γ-secretase inhibitor)Selleck ChemicalsS7999Test compound - osteoclast inhibitor
M-CSF (Macrophage Colony-Stimulating Factor)R&D Systems416-ML-010Macrophage survival and osteoclast differentiation
Micro-CT scannerBrukerSkyScan 1272Bone microarchitecture analysis
Microplate readerBioTekSynergy H1Absorbance measurements (CCK-8)
MicrotomeLeicaRM2255Histological sectioning
Naphthol AS-MX phosphateSigma-AldrichN5000TRAP staining substrate
Needles (25G, 27G)BD305122, 305109Bone marrow flushing, injections
NRecon softwareBrukerVersion 1.7Micro-CT image reconstruction
Paraffin waxSigma-AldrichP3683Tissue embedding
Paraformaldehyde (4%)Sigma-AldrichP6148Cell and tissue fixation
PBS (Phosphate Buffered Saline)Gibco/Thermo Fisher14190-144Cell washing and buffer preparation
Pentobarbital sodiumSigma-AldrichP3761Animal anesthesia and euthanasia
Phosphatase inhibitor cocktailRoche4906837001Phosphorylation preservation
PowerUp SYBR Green Master MixApplied BiosystemsA25742Quantitative real-time PCR
Protease inhibitor cocktailRoche11697498001Protein degradation prevention
PVDF membrane (0.45 μm)Bio-Rad1620177Western blot protein transfer
RANKL (Receptor Activator of NF-κB Ligand)R&D Systems462-TEC-010Osteoclast differentiation induction
Real-time PCR systemApplied Biosystems7500 FastQuantitative gene expression analysis
Rhodamine-phalloidinInvitrogen/Thermo FisherR415F-actin visualization
RIPA bufferCell Signaling Technology9806SProtein extraction
RNase-free waterAmbion/Thermo FisherAM9937RNA dissolution and PCR
SDS-PAGE gels (10%)Bio-Rad4561036Western blot protein separation
Skim milk powderBio-Rad1706404Western blot blocking
Sodium acetate buffer (0.1 M, pH 5.0)Sigma-AldrichS2889TRAP staining buffer
Sodium tartrate (50 mM)Sigma-AldrichS4297TRAP staining specificity
SpectrophotometerThermo FisherNanoDrop 2000RNA/protein concentration measurement
SPSSIBM CorporationVersion 28.0Statistical analysis
Syringes (1 mL, 10 mL)BD309659, 309604Bone marrow flushing, injections
T75 cell culture flasksCorning430641Primary BMM culture
TBST (Tris-Buffered Saline with 0.1% Tween-20)Bio-Rad1706531Western blot washing buffer
Transfer bufferBio-Rad1704270Western blot protein transfer
Triton X-100Sigma-AldrichT8787Cell permeabilization
TRIzol reagentInvitrogen/Thermo Fisher15596026Total RNA extraction
Trypan blue (0.4%)Sigma-AldrichT8154Cell viability assessment
Trypsin-EDTA (0.25%)Gibco/Thermo Fisher25200-056Cell harvesting and detachment
Western blot transfer systemBio-RadTrans-Blot TurboProtein transfer to membrane
XyleneSigma-AldrichX3750Tissue processing and clearing
α-MEM (Alpha Minimum Essential Medium)Gibco/Thermo Fisher12561-056Cell culture medium

References

  1. Langdahl, B., Ferrari, S., Dempster, D. W. Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. Ther Adv Musculoskeletal Dis. 8 (6), 225-235 (2016).
  2. Shah, M. A. A., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Osteoclastogenesis InhibitionLY900009RANKL Induced OsteoclastsBone ResorptionBone Marrow MacrophagesWestern BlotTRAP StainingMAPK Akt Pathway